- Home
- STIM
STIM
Neuronetics Inc.
as 07-26-2024 4:00pm EST
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | MALVERN |
| Market Cap: | 57.7M | IPO Year: | 2018 |
| Target Price: | $8.00 | AVG Volume (30 days): | 118.7K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.03 - $5.07 | Next Earning Date: | 08-06-2024 |
| Revenue: | $73,225,000 | Revenue Growth: | 10.01% |
| Revenue Growth (this year): | 13.15% | Revenue Growth (next year): | 13.49% |
Stock Insider Trading Activity of Neuronetics Inc. (STIM)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sullivan Keith J | STIM | President and CEO | Jul 16 '24 | Sell | $1.97 | 11,687 | $23,023.39 | 1,348,516 | SEC Form 4 |
| Sullivan Keith J | STIM | President and CEO | Jul 16 '24 | Sell | $1.91 | 12,075 | $23,063.25 | 1,360,203 | SEC Form 4 |
| CASCELLA ROBERT | STIM | Director | Jun 6 '24 | Buy | $2.05 | 50,000 | $102,550.00 | 244,098 | SEC Form 4 |
| MACAN WILLIAM ANDREW | STIM | EVP, GC, CCO and CS | Feb 28 '24 | Sell | $3.16 | 22,377 | $70,711.32 | 395,359 | SEC Form 4 |
| MACAN WILLIAM ANDREW | STIM | EVP, GC, CCO and CS | Feb 28 '24 | Sell | $2.94 | 6,026 | $17,716.44 | 389,333 | SEC Form 4 |
| Furlong Stephen | STIM | EVP, CFO and Treasurer | Feb 27 '24 | Sell | $3.33 | 21,272 | $70,835.76 | 487,761 | SEC Form 4 |
| Furlong Stephen | STIM | EVP, CFO and Treasurer | Feb 27 '24 | Sell | $3.16 | 3,985 | $12,592.60 | 483,776 | SEC Form 4 |
| Sullivan Keith J | STIM | President and CEO | Feb 26 '24 | Sell | $3.30 | 20,292 | $66,963.60 | 1,372,278 | SEC Form 4 |
| Sullivan Keith J | STIM | President and CEO | Feb 22 '24 | Sell | $3.23 | 20,851 | $67,348.73 | 1,413,320 | SEC Form 4 |
| Sullivan Keith J | STIM | President and CEO | Feb 22 '24 | Sell | $3.23 | 20,750 | $67,022.50 | 1,392,570 | SEC Form 4 |
| Sullivan Keith J | STIM | President and CEO | Feb 20 '24 | Sell | $2.96 | 23,958 | $70,915.68 | 1,434,171 | SEC Form 4 |
| MACAN WILLIAM ANDREW | STIM | EVP, GC, CCO and CS | Feb 14 '24 | Sell | $3.38 | 15,621 | $52,798.98 | 417,736 | SEC Form 4 |
| Furlong Stephen | STIM | EVP, CFO and Treasurer | Feb 9 '24 | Sell | $3.51 | 14,710 | $51,632.10 | 509,033 | SEC Form 4 |
| MACAN WILLIAM ANDREW | STIM | EVP, GC, CCO and CS | Feb 5 '24 | Sell | $3.39 | 5,385 | $18,255.15 | 433,357 | SEC Form 4 |
| Furlong Stephen | STIM | EVP, CFO and Treasurer | Feb 5 '24 | Sell | $3.39 | 5,813 | $19,706.07 | 523,743 | SEC Form 4 |
| Sullivan Keith J | STIM | President and CEO | Jan 10 '24 | Sell | $3.01 | 10,013 | $30,139.13 | 1,167,645 | SEC Form 4 |
| Sullivan Keith J | STIM | President and CEO | Jan 10 '24 | Sell | $3.16 | 9,516 | $30,070.56 | 1,158,129 | SEC Form 4 |
| MACAN WILLIAM ANDREW | STIM | EVP, GC, CCO and CS | Dec 19 '23 | Sell | $2.24 | 11,664 | $26,127.36 | 372,069 | SEC Form 4 |
| MACAN WILLIAM ANDREW | STIM | EVP, GC, CCO and CS | Dec 19 '23 | Sell | $2.70 | 11,664 | $31,492.80 | 360,405 | SEC Form 4 |
| MACAN WILLIAM ANDREW | STIM | EVP, GC, CCO and CS | Dec 19 '23 | Sell | $2.52 | 11,663 | $29,390.76 | 348,742 | SEC Form 4 |
Latest Neuronetics Inc. News
STIM Breaking Stock News: Dive into STIM Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
Medical Device Network
15 days ago
TMS in California will have Medicaid coverage for major depressive disorder patients
GlobeNewswire
15 days ago
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
GlobeNewswire
16 days ago
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
Zacks
24 days ago
Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch
GlobeNewswire
25 days ago
NeuroStar® Launches Better Me Provider Program Nationwide
GlobeNewswire
a month ago
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
Compare STIM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STIM Neuronetics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.